GlaxoSmithKline turns into losses in the first quarterVisits : 63

GlaxoSmithKline turns into losses in the first quarter

The consolidated financial statements of GlaxoSmithKline (BIOC) during the first quarter of this year showed its conversion to losses, on an annual basis. The company said in a statement to the Egyptian Stock Exchange, on Tuesday, it made a loss during the period amounted to 7.55 million pounds